LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Recommendation of “Moderate Buy” by Analysts
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight ratings firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and six have issued a buy rating on […]
27 Mar 10:39 · The Cerbat Gem